Cargando…
Mediastinal and pleural lipomatosis as a manifestation of myotonic dystrophy type 1
Mediastinal and pleural lipomatosis is a rare but usually benign and asymptomatic disease. Mediastinal lipomatosis is associated with steroid use, obesity, hyperlipidemia, diabetes, or Cushing syndrome. In some cases, it becomes symptomatic manifesting with dyspnea, thoracic pain, coughing, dysphoni...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509172/ https://www.ncbi.nlm.nih.gov/pubmed/34472530 http://dx.doi.org/10.4103/lungindia.lungindia_25_21 |
_version_ | 1784582271773179904 |
---|---|
author | Finsterer, Josef Scorza, Fulvio A |
author_facet | Finsterer, Josef Scorza, Fulvio A |
author_sort | Finsterer, Josef |
collection | PubMed |
description | Mediastinal and pleural lipomatosis is a rare but usually benign and asymptomatic disease. Mediastinal lipomatosis is associated with steroid use, obesity, hyperlipidemia, diabetes, or Cushing syndrome. In some cases, it becomes symptomatic manifesting with dyspnea, thoracic pain, coughing, dysphonia, dysphagia, supraventricular tachycardia, or persistent pneumonia. Mediastinal lipomatosis has not been reported in association with myotonic dystrophy type 1 (MD1). In a 65yo male with a long-term history of progressive muscle weakness, hyper-creatine-kinase-emia, bilateral cataract, sleep apnea syndrome, gynecomastia, hepatic steatosis, arterial hypertension, atrioventricular block 1, QTc prolongation, hyperlipidemia, hyperuricemia, and hepatopathy, MD1 was diagnosed upon the clinical presentation and a heterozygous CTG repeat expansion of 1200–1400 repeats in DMPK. Work-up for dyspnea and leg edema revealed heart failure and mediastinal and pleural lipomatosis. Upon standard treatment, heart failure resolved. In conclusion, mediastinal and pleural lipomatosis can be a rare manifestation of MD1 and can manifest with heart failure. In patients with mediastinal lipomatosis, MD1 should be excluded. |
format | Online Article Text |
id | pubmed-8509172 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-85091722021-11-01 Mediastinal and pleural lipomatosis as a manifestation of myotonic dystrophy type 1 Finsterer, Josef Scorza, Fulvio A Lung India Case Report Mediastinal and pleural lipomatosis is a rare but usually benign and asymptomatic disease. Mediastinal lipomatosis is associated with steroid use, obesity, hyperlipidemia, diabetes, or Cushing syndrome. In some cases, it becomes symptomatic manifesting with dyspnea, thoracic pain, coughing, dysphonia, dysphagia, supraventricular tachycardia, or persistent pneumonia. Mediastinal lipomatosis has not been reported in association with myotonic dystrophy type 1 (MD1). In a 65yo male with a long-term history of progressive muscle weakness, hyper-creatine-kinase-emia, bilateral cataract, sleep apnea syndrome, gynecomastia, hepatic steatosis, arterial hypertension, atrioventricular block 1, QTc prolongation, hyperlipidemia, hyperuricemia, and hepatopathy, MD1 was diagnosed upon the clinical presentation and a heterozygous CTG repeat expansion of 1200–1400 repeats in DMPK. Work-up for dyspnea and leg edema revealed heart failure and mediastinal and pleural lipomatosis. Upon standard treatment, heart failure resolved. In conclusion, mediastinal and pleural lipomatosis can be a rare manifestation of MD1 and can manifest with heart failure. In patients with mediastinal lipomatosis, MD1 should be excluded. Wolters Kluwer - Medknow 2021 2021-08-30 /pmc/articles/PMC8509172/ /pubmed/34472530 http://dx.doi.org/10.4103/lungindia.lungindia_25_21 Text en Copyright: © 2021 Indian Chest Society https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Case Report Finsterer, Josef Scorza, Fulvio A Mediastinal and pleural lipomatosis as a manifestation of myotonic dystrophy type 1 |
title | Mediastinal and pleural lipomatosis as a manifestation of myotonic dystrophy type 1 |
title_full | Mediastinal and pleural lipomatosis as a manifestation of myotonic dystrophy type 1 |
title_fullStr | Mediastinal and pleural lipomatosis as a manifestation of myotonic dystrophy type 1 |
title_full_unstemmed | Mediastinal and pleural lipomatosis as a manifestation of myotonic dystrophy type 1 |
title_short | Mediastinal and pleural lipomatosis as a manifestation of myotonic dystrophy type 1 |
title_sort | mediastinal and pleural lipomatosis as a manifestation of myotonic dystrophy type 1 |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509172/ https://www.ncbi.nlm.nih.gov/pubmed/34472530 http://dx.doi.org/10.4103/lungindia.lungindia_25_21 |
work_keys_str_mv | AT finstererjosef mediastinalandpleurallipomatosisasamanifestationofmyotonicdystrophytype1 AT scorzafulvioa mediastinalandpleurallipomatosisasamanifestationofmyotonicdystrophytype1 |